Skip to content

Erasca, Inc. ERAS Other income, net (Note 6)

Other income, net (Note 6) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$32M+90.6%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$1.08M+0.5%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$5.3M-32.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$140K-2,700%
Pfizer logo
PfizerPFE
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s other income, net (note 6)?
Erasca, Inc. (ERAS) reported other income, net (note 6) of $22K in Q1 2026.
How has Erasca, Inc.'s other income, net (note 6) changed year-over-year?
Erasca, Inc.'s other income, net (note 6) increased by 128.9% year-over-year, from -$76K to $22K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.